Title : The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article).

Pub. Date : 2019 Dec

PMID : 31861037






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Statins therapy decrease both low-density lipoprotein cholesterol (LDL-C) levels and the risk of atherosclerotic cardiovascular disease (ASCVD) with considerable individual variability. Simvastatin component of oligomeric golgi complex 2 Homo sapiens
2 Statins therapy decrease both low-density lipoprotein cholesterol (LDL-C) levels and the risk of atherosclerotic cardiovascular disease (ASCVD) with considerable individual variability. Simvastatin component of oligomeric golgi complex 2 Homo sapiens